News Search Results for "Hematologic"
Bookmark and Share
(About Results)

View Results by:
Vivakor Confirms Record Date of Stock Dividend
CORALVILLE, Iowa, Dec. 4 /PRNewswire-FirstCall/ -- Vivakor, Inc. (OTC Bulletin Board: VIVK) today confirmed that its shareholders of record on December 1, 2009 will receive the dividend of ...
redOrbit, Fri Dec 04 17:08:00 PST 2009 • Found on Yahoo! News
Dana-Farber Cancer Institute receives 2009 MMRC Center of the Year Award
The Multiple Myeloma Research Consortium (MMRC) today announced that it has awarded the Dana-Farber Cancer Institute, and its clinical researchers, Kenneth Anderson, MD, and Paul Richardson...
News-Medical-Net, Fri Dec 04 22:01:00 PST 2009 • Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Quest Diagnostics Reveals New Genetic Discoveries For Testing For Leukemia, Lympho...
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of seve...
Medical News Today, Fri Dec 04 05:25:30 PST 2009 • Found on Yahoo! News
BioTime CEO Dr. Michael West to Ring The Opening Bell at the New York Stock Exchan...
ALAMEDA, Calif.----BioTime, Inc. Chief Executive Officer Michael D. West, Ph.D. will ring The Opening Bell at the New York Stock Exchange at 9:30 a.m. Eastern on Tuesday, December 8, 2009.
Business Wire via Yahoo! Finance, Fri Dec 04 11:01:00 PST 2009 • Found on Yahoo! News
FDA approves once-daily SEROQUEL XR Extended Release Tablets
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatme...
News-Medical-Net, Fri Dec 04 04:46:01 PST 2009 • Found on Yahoo! News
Ortho Biotech Oncology Research & Development Data to Be Presented at the 51st Ann...
BEERSE, Belgium, December 4 /PRNewswire/ -- - Note: This release corresponds to ASH abstracts 109, 131, 2312, 3859 and 3875 Ortho Biotech Oncology Research & Development, a division of Jans...
ITNews, Fri Dec 04 01:58:18 PST 2009 • Found on Yahoo! News
Vivakor Confirms Record Date of Stock Dividend
Vivakor, Inc. today confirmed that its shareholders of record on December 1, 2009 will receive the dividend of shares of common stock of HealthAmerica, Inc. that was previously approved by ...
PR Newswire via Yahoo! Finance, Fri Dec 04 11:09:00 PST 2009 • Found on Yahoo! News
New discoveries to treat life-threatening blood disorder presented at ASH annual m...
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of seve...
News-Medical-Net, Fri Dec 04 04:16:01 PST 2009 • Found on Yahoo! News
ZIOPHARM Prices Public Offering
NEW YORK----ZIOPHARM Oncology, Inc. announced the pricing of its previously announced underwritten public offering of 15,484,000 shares of its common stock and warrants to purchase 7,742,00...
Business Wire via Yahoo! Finance, Fri Dec 04 06:31:00 PST 2009 • Found on Yahoo! News
Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lympho...
MADISON, N.J., Dec.
redOrbit, Thu Dec 03 15:08:00 PST 2009 • Found on Yahoo! News
Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program fo...
WESTMINSTER, Colo.----Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOT...
Business Wire via Yahoo! Finance, Fri Dec 04 05:00:00 PST 2009 • Found on Yahoo! News
Pfizer To Present Clinical Data From Expanded Breast Cancer Portfolio At The San A...
NEW YORK----Pfizer Oncology announced today that it will be presenting study findings evaluating several compounds including those from its newly expanded breast cancer portfolio following ...
Business Wire via Yahoo! Finance, Fri Dec 04 05:00:00 PST 2009 • Found on Yahoo! News
ZIOPHARM Announces Commencement of Public Offering
NEW YORK----ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securit...
Business Wire via Yahoo! Finance, Thu Dec 03 13:02:00 PST 2009 • Found on Yahoo! News
Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lympho...
A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of seve...
PR Newswire via Yahoo! Finance, Thu Dec 03 13:10:00 PST 2009 • Found on Yahoo! News
51st Annual Meeting Of The American Society Of Hematology Will Highlight Research ...
The American Society of Hematology (ASH), the world's largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Meeting from December ...
Medical News Today, Thu Dec 03 04:41:13 PST 2009 • Found on Yahoo! News
ISTODAX® Incorporated Into NCCN Clinical Practice Guidelines in Oncology for the T...
CAMBRIDGE, Mass.----Gloucester Pharmaceuticals announced today that ISTODAX® has been included in the updated National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology
Business Wire via Yahoo! Finance, Thu Dec 03 08:33:00 PST 2009 • Found on Yahoo! News
More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be...
Bristol-Myers Squibb Company today announced that more than 80 abstracts highlighting compounds from the company
News-Medical-Net, Wed Dec 02 23:30:44 PST 2009 • Found on Yahoo! News
Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell L...
WESTMINSTER, Colo.----Allos Therapeutics, Inc. today announced the launch of an international registry designed to address the urgent need to better understand treatment patterns and outcom...
Business Wire via Yahoo! Finance, Thu Dec 03 05:00:00 PST 2009 • Found on Yahoo! News
Calistoga Pharmaceuticals Announces Two Oral Presentations on CAL-101 at 51st Amer...
SEATTLE----Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase inhibitors for the treatment of cancer and inflammatory diseases...
Business Wire via Yahoo! Finance, Tue Dec 01 05:03:00 PST 2009 • Found on Yahoo! News
1 2 Next
Arfie
Infospace™
© 2009 InfoSpace, Inc. All Rights Reserved